The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, introduces the Revamped Pharmaceuticals Technology Upgradation Assistance Scheme to enhance industry capabilities and align with global standards. Its approval follows a thorough review by the Scheme Steering Committee, considering the revised Schedule-M of the Drugs and Cosmetics Rule, 1945.

Key Features of the Revised Scheme

Broadened Eligibility Criteria

• Expanded eligibility to include any pharmaceutical manufacturing unit with a turnover of less than 500 crores requiring technology and quality upgradation.
• Preference for Micro, Small, and Medium Enterprises (MSMEs) to support smaller players in achieving high-quality manufacturing standards.

Flexible Financing Options

• Introduces subsidies on a reimbursement basis over the traditional credit-linked approach.
• Diversifies financing options, facilitating widespread adoption.

Comprehensive Support for Compliance with New Standards

• Supports a broader range of technological upgrades in alignment with revised Schedule-M and WHO-GMP standards.
• Eligible activities include improvements in HVAC systems, utilities, testing laboratories, clean room facilities, etc.

Dynamic Incentive Structure

• Pharmaceutical units meeting turnover criteria eligible for incentives up to Rs. 1.00 crore per unit.
• Incentive structure varies based on turnover, incentivizing growth across different scales of operations.
• Below table explains incentives for companies:

• Turnover Range (in Crores)	Incentives
  Less than Rs. 50.00 crore	20% of investment under eligible activities
  Rs. 50.00 crore to less than Rs. 250.00 crore	15% of investment under eligible activities
  Rs. 250.00 crore to less than Rs. 500.00 crore	10% of investment under eligible activities

State Government Scheme Integration

• Allows integration with state government schemes, enabling additional top-up assistance.
• Aims to maximize support for the pharmaceutical industry in technology upgradation efforts.

Enhanced Verification Mechanism

• Introduces a robust verification mechanism through a Project Management Agency.
• Ensures transparency, accountability, and efficient resource allocation.

Government’s Commitment to Industry Growth

• The reform in the PTUAS Scheme will catalyze the growth of the pharmaceutical industry and enhance its compliance with global manufacturing standards.
• By revamping the scheme, the government reaffirms its unwavering commitment to supporting a critical industry for the nation’s health and well-being, ensuring its competitiveness on the global stage.